The store will not work correctly when cookies are disabled.
6-(2,4-difluorophenyl)-N-(pyridin-4-yl)-1H-pyrrolo[2,3-b]pyridin-4-amine
ID: ALA4446613
PubChem CID: 155518651
Max Phase: Preclinical
Molecular Formula: C18H12F2N4
Molecular Weight: 322.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Fc1ccc(-c2cc(Nc3ccncc3)c3cc[nH]c3n2)c(F)c1
Standard InChI: InChI=1S/C18H12F2N4/c19-11-1-2-13(15(20)9-11)16-10-17(14-5-8-22-18(14)24-16)23-12-3-6-21-7-4-12/h1-10H,(H2,21,22,23,24)
Standard InChI Key: ILRGLUAABODDJU-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
9.3963 -4.2180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3951 -5.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1032 -5.4465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1014 -3.8091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8100 -4.2144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8103 -5.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5932 -5.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0770 -4.6256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5928 -3.9598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0990 -2.9919 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3900 -2.5855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3909 -1.7690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6828 -1.3626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9754 -1.7734 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9805 -2.5948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6891 -2.9975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6890 -5.4458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9813 -5.0350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2738 -5.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2727 -6.2604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9851 -6.6694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6897 -6.2597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3982 -6.6669 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.5652 -6.6694 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
2 17 1 0
22 23 1 0
20 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.32 | Molecular Weight (Monoisotopic): 322.1030 | AlogP: 4.65 | #Rotatable Bonds: 3 |
Polar Surface Area: 53.60 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.95 | CX LogP: 3.76 | CX LogD: 3.24 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -1.27 |
References
1. Wang H, Lawson JD, Scorah N, Kamran R, Hixon MS, Atienza J, Dougan DR, Sabat M.. (2016) Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors., 26 (17): [PMID:27460209] [10.1016/j.bmcl.2016.07.030] |